Etodolac induced acute interstitial nephritis and autoimmune hemolytic anemia

In spite of the widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) such as etodolac, induction of drug-dependent antibodies that cause hemolytic anemia and acute tubulointerstitiel nephritis are rarely reported. Currently, there is no way of identifying individuals who are at risk to...

Full description

Bibliographic Details
Main Authors: Haci Bayram Berktas, Irem Pembegul Yigit, Hulya Taskapan, Nusret Akpolat
Format: Article
Language:English
Published: Society of TURAZ AKADEMI 2016-12-01
Series:Medicine Science
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=223964
Description
Summary:In spite of the widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) such as etodolac, induction of drug-dependent antibodies that cause hemolytic anemia and acute tubulointerstitiel nephritis are rarely reported. Currently, there is no way of identifying individuals who are at risk to develop this kind of complications. In patients who present with acute immune hemolysis and acute renal failure, it is important that a careful history of medication be obtained, potential sensitizing medications be identified. In this article we describe a patient with acute autoimmune hemolytic anemia and acute renal failure related with etodolac. [Med-Science 2016; 5(4.000): 1030-2]
ISSN:2147-0634